发明名称 Indoline compounds as granzyme B inhibitors
摘要 Granzyme B inhibitor compounds, compositions that include the compounds, and methods for using the compounds. The compounds of the invention have advantageous water solubility and effectively inhibit Granzyme B.
申请公布号 US9605021(B2) 申请公布日期 2017.03.28
申请号 US201514869750 申请日期 2015.09.29
申请人 viDA Therapeutics Inc. 发明人 Cameron Dale R.
分类号 C07K5/097;C07K5/083;C07K5/087;C07K5/08;A61K38/00 主分类号 C07K5/097
代理机构 Christensen O'Connor Johnson Kindness PLLC 代理人 Christensen O'Connor Johnson Kindness PLLC
主权项 1. A compound having Formula (I): its stereoisomers and pharmaceutically acceptable salts thereof, wherein: R1a is a heteroaryl group selected from (a) 1,2,3-triazolyl optionally substituted with C1-C2 alkyl,(b) 1,2,3,4-tetrazolyl, and(c) 1,2,3-thiadiazolyl; R1b and R1c are independently selected from hydrogen, methyl, and halogen; R2a and R2b are independently selected from hydrogen and methyl, or R2a and R2b taken together are oxo; n is 1 or 2; R3 is selected from hydrogen and C1-C4 alkyl optionally substituted with a carboxylic acid or a carboxylate group or an amine group; Z is an acyl group selected from the group (a) (b) wherein o is 1 or 2, and R5a is C4-acyl substituted with a carboxylic acid; (c) wherein p is 1 or 2, and R5a is C4-acyl substituted with a carboxylic acid; and (d) wherein Y is heteroaryl; whereinR4 is selected from (i) C1-C12 alkyl,(ii) C1-C6 heteroalkyl optionally substituted with C1-C6 alkyl,(iii) C3-C6 cycloalkyl,(iv) C6-C10 aryl,(v) heterocyclyl,(vi) C3-C10 heteroaryl,(vii) aralkyl, and(viii) heteroalkylaryl;R5 is —C(═O)—R10, wherein R10 is selected from (i) C1-C12 alkyl optionally substituted with C6-C10 aryl, optionally substituted C3-C10 heteroaryl, amino, or carboxylic acid,(ii) C1-C10 heteroalkyl optionally substituted with C1-C6 alkyl or carboxylic acid,(iii) C3-C6 cycloalkyl optionally substituted with C1-C6 alkyl, optionally substituted C6-C10 aryl, optionally substituted C3-C10 heteroaryl, amino, or carboxylic acid,(iv) C6-C10 aryl optionally substituted with C1-C6 alkyl, optionally substituted C6-C10 aryl, optionally substituted C3-C10 heteroaryl, amino, or carboxylic acid,(v) heterocyclyl,(vi) C3-C10 heteroaryl,(vii) aralkyl, and(viii) heteroalkylaryl; and R6, R7, R8, and R9 are independently selected from (a) hydrogen,(b) halogen,(c) C1-C6 alkyl,(d) —XR11, wherein X is selected from O, C(═O), S, S═O, or S(═O)2,(e) —C(═O)N(R12)(R13),(f) —N(R11)(R12)(R13),(g) —N—C(═O)—R11, and(h) —N—C(═O)O—R11,wherein R11, R12, and R13 are independently selected from the group consisting of hydrogen, C1-C6 alkyl, C1-C6 heteroalkyl, C2-C6 alkenyl, C6-C10 aryl, aralkyl, and C3-C10 heteroaryl.
地址 Vancouver CA